Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia
Keywords:
Apoptosis; BCR-ABL/T315I; CML; Imatinib-resistance; Inhibition; Plumbagin.Abstract
Development of a new inhibitor of BCR-ABL tyrosine kinase is necessary for the treatment of chronic myeloid leukemia (CML) because of increasing resistance and tolerance to Imatinid efforts. Herein, we reported Plumbagin can significantly inhibit the growth of CML. The results revealed that Plumbagin inhitbited TCCY and TCCY/T315I cells with IC50 values 3 μM and 2.1 μM, respectively. Plumbagin also showed anti-proliferative effects on both the wide type Ba/F3 and the BCR-ABL-transfected Ba/F3 cells with a range of IC50 from 3.2 to 3.8 μM. In addition, Plumbagin induced the apoptosis of CML cells. That would provide a new and potential drug as a chemotherapy medication in the treatment of Imatinid -resistant CML.Downloads
Download data is not yet available.
References
Downloads
Received:
04-06-2020
Accepted:
04-06-2020
Published:
09-08-2017
Statistics
Abstract: 301 PDF: 234How to Cite
Ly, B. T. K., Chi, H. T., Phuong, Q. N. D., & Quyen, H. B. T. (2017). Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia. Ho Chi Minh City Open University Journal of Science - Engineering and Technology, 7(1), 30–35. Retrieved from https://journalofscience.ou.edu.vn/index.php/tech-en/article/view/366
License
Copyright (c) 2017 Bui Thi Kim Ly; Hoang Thanh Chi; Quach Ngo Diem Phuong; Ho Bao Thuy Quyen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.